Literature DB >> 28593528

The neuropathological basis to the functional role of microglia/macrophages in gliomas.

Davide Schiffer1, Marta Mellai2, Enrica Bovio2, Laura Annovazzi2.   

Abstract

The paper wants to be a tracking shot of the main recent acquisitions on the function and significance of microglia/macrophages in gliomas. The observations have been principally carried out on in vitro cultures and on tumor transplants in animals. Contrary to what is deduced from microglia in non-neoplastic pathologic conditions of central nervous system (CNS), most conclusions indicate that microglia acts favoring tumor proliferation through an immunosuppression induced by glioma cells. By immunohistochemistry, different microglia phenotypes are recognized in gliomas, from ramified microglia to frank macrophagic aspect. One wonders whether the functional conclusions drawn from many microglia studies, but not in conditions of human pathology, apply to all the phenotypes recognizable in them. It is difficult to verify in human pathology a prognostic significance of microglia. Only CD163-positive microglia/macrophages inversely correlate with glioma patients' survival, whereas the total number of microglia does not change with the malignancy grade.

Entities:  

Keywords:  Gliomas; Microglia

Mesh:

Substances:

Year:  2017        PMID: 28593528     DOI: 10.1007/s10072-017-3002-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  62 in total

1.  Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system.

Authors:  Iftach Shaked; Ziv Porat; Roman Gersner; Jonathan Kipnis; Michal Schwartz
Journal:  J Neuroimmunol       Date:  2004-01       Impact factor: 3.478

Review 2.  Physiology of microglia.

Authors:  Helmut Kettenmann; Uwe-Karsten Hanisch; Mami Noda; Alexei Verkhratsky
Journal:  Physiol Rev       Date:  2011-04       Impact factor: 37.312

3.  Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma.

Authors:  Tian Qin; Chenlong Wang; Xuewei Chen; Chenfan Duan; Xiaoyan Zhang; Jing Zhang; Hongyan Chai; Tian Tang; Honglei Chen; Jiang Yue; Ying Li; Jing Yang
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-25       Impact factor: 4.219

4.  Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling.

Authors:  Salvatore J Coniglio; Eliseo Eugenin; Kostantin Dobrenis; E Richard Stanley; Brian L West; Marc H Symons; Jeffrey E Segall
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 5.  Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy.

Authors:  Neha Kamran; Mayuri Chandran; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Immunol       Date:  2016-10-21       Impact factor: 3.969

6.  Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers.

Authors:  Michael Prosniak; Larry A Harshyne; David W Andrews; Lawrence C Kenyon; Kamila Bedelbaeva; Tatiyana V Apanasovich; Ellen Heber-Katz; Mark T Curtis; Paolo Cotzia; D Craig Hooper
Journal:  Clin Cancer Res       Date:  2013-06-05       Impact factor: 12.531

7.  Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Authors:  Y Komohara; K Ohnishi; J Kuratsu; M Takeya
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

Review 8.  The role of astrocytes in the progression of brain cancer: complicating the picture of the tumor microenvironment.

Authors:  Amanda L Placone; Alfredo Quiñones-Hinojosa; Peter C Searson
Journal:  Tumour Biol       Date:  2015-10-22

9.  Tumor-associated macrophages in glioma: friend or foe?

Authors:  Benjamin C Kennedy; Christopher R Showers; David E Anderson; Lisa Anderson; Peter Canoll; Jeffrey N Bruce; Richard C E Anderson
Journal:  J Oncol       Date:  2013-05-08       Impact factor: 4.375

10.  Periostin: a potent chemotactic factor for recruiting tumor-associated macrophage.

Authors:  Tiantian Wu; Qi Luo; Gaoliang Ouyang
Journal:  Protein Cell       Date:  2015-04       Impact factor: 14.870

View more
  10 in total

Review 1.  Glioblastoma niches: from the concept to the phenotypical reality.

Authors:  Davide Schiffer; Marta Mellai; Enrica Bovio; Ilaria Bisogno; Cristina Casalone; Laura Annovazzi
Journal:  Neurol Sci       Date:  2018-05-08       Impact factor: 3.307

2.  Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools.

Authors:  Silvana Valdebenito; Daniela D'Amico; Eliseo Eugenin
Journal:  Cancer Rep (Hoboken)       Date:  2019-11-11

Review 3.  Advances in Nanotechnology-Based Immunotherapy for Glioblastoma.

Authors:  Lin Tang; Ming Zhang; Chaoyong Liu
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

4.  Identification of Aberrantly Expressed Genes in Murine Glioblastoma During Radiotherapy via Bioinformatic Data Mining.

Authors:  Xihe Zhao; Chenxi Li; Lei Liu; Huawei Zou; Kai Li
Journal:  Onco Targets Ther       Date:  2020-05-06       Impact factor: 4.147

Review 5.  Bidirectional Microglia-Neuron Communication in Health and Disease.

Authors:  Zsuzsanna Szepesi; Oscar Manouchehrian; Sara Bachiller; Tomas Deierborg
Journal:  Front Cell Neurosci       Date:  2018-09-27       Impact factor: 5.505

6.  SEL1L plays a major role in human malignant gliomas.

Authors:  Marta Mellai; Laura Annovazzi; Renzo Boldorini; Luca Bertero; Paola Cassoni; Pasquale De Blasio; Ida Biunno; Davide Schiffer
Journal:  J Pathol Clin Res       Date:  2019-09-30

7.  Microglia immunophenotyping in gliomas.

Authors:  Laura Annovazzi; Marta Mellai; Enrica Bovio; Samanta Mazzetti; Bianca Pollo; Davide Schiffer
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

Review 8.  Enforced microglial depletion and repopulation as a promising strategy for the treatment of neurological disorders.

Authors:  Jinming Han; Keying Zhu; Xing-Mei Zhang; Robert A Harris
Journal:  Glia       Date:  2018-10-30       Impact factor: 7.452

9.  Fingolimod Augments Monomethylfumarate Killing of GBM Cells.

Authors:  Paul Dent; Laurence Booth; Jane L Roberts; Andrew Poklepovic; John F Hancock
Journal:  Front Oncol       Date:  2020-01-28       Impact factor: 6.244

10.  Multiple Irradiation Affects Cellular and Extracellular Components of the Mouse Brain Tissue and Adhesion and Proliferation of Glioblastoma Cells in Experimental System In Vivo.

Authors:  Maxim O Politko; Alexandra Y Tsidulko; Oxana A Pashkovskaya; Konstantin E Kuper; Anastasia V Suhovskih; Galina M Kazanskaya; Lyubov S Klyushova; Dmitry K Sokolov; Alexander M Volkov; Evgenii E Kliver; Alexander A Zheravin; Svetlana V Aidagulova; Elvira V Grigorieva
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.